Barclays lowered the firm’s price target on Amphastar (AMPH) to $23 from $30 and keeps an Equal Weight rating on the shares. The firm says is encouraged by the company’s recent approvals but says its broader momentum has slowed.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMPH:
- Amphastar Expands Share Repurchase Authorization to Manage Equity
- Amphastar Updates Executive Employment Agreements to Strengthen Leadership
- Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks
- Amphastar price target lowered to $30 from $34 at Wells Fargo
- Amphastar reports Q4 EPS 73c, consensus 92c